相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy
Misako Matsumoto et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Trial watch: TLR3 agonists in cancer therapy
Julie Le Naour et al.
ONCOIMMUNOLOGY (2020)
A Toll-like receptor 3 (TLR3) agonist ARNAX for therapeutic immunotherapy
Tsukasa Seya et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)-Mediated Anti-tumor Therapy
Julia Koerner et al.
FRONTIERS IN IMMUNOLOGY (2019)
Utility of the RIG-I Agonist Triphosphate RNA for Melanoma Therapy
Mike W. Helms et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer A Phase 2 Clinical Trial
Erminia Massarelli et al.
JAMA ONCOLOGY (2019)
Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity
Linda Schadt et al.
CELL REPORTS (2019)
Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis
Isabell Schau et al.
SCIENTIFIC REPORTS (2019)
Fates of CD8+ T cells in Tumor Microenvironment
Nomathamsanqa Resegofetse Maimela et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Vaccine immunotherapy with ARNAX induces tumor-specific memory T cells and durable anti-tumor immunity in mouse models
Yohei Takeda et al.
CANCER SCIENCE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer
Charles B. Chesson et al.
NANOMEDICINE (2017)
Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis
Tyler J. Goodwin et al.
VACCINE (2017)
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
Ruan F. V. Medrano et al.
ONCOTARGET (2017)
A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy
Yohei Takeda et al.
CELL REPORTS (2017)
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
Cara L. Haymaker et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy
Misako Matsumoto et al.
FRONTIERS IN IMMUNOLOGY (2017)
Phenotype, function, and differentiation potential of human monocyte subsets
Lisa B. Boyette et al.
PLOS ONE (2017)
Exploiting poly(I:C) to induce cancer cell apoptosis
Francesca Bianchi et al.
CANCER BIOLOGY & THERAPY (2017)
The STEAP1262-270 peptide encapsulated into PLGA microspheres elicits strong cytotoxic T cell immunity in HLA-A*0201 transgenic miceA new approach to immunotherapy against prostate carcinoma
Valerie L. Herrmann et al.
PROSTATE (2016)
Tumor vaccines with dsRNA adjuvant ARNAX induces antigen-specific tumor shrinkage without cytokinemia
Tsukasa Seya et al.
ONCOIMMUNOLOGY (2016)
Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
Yusuf Dolen et al.
ONCOIMMUNOLOGY (2016)
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease
Valerie L. Herrmann et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo
Misako Matsumoto et al.
NATURE COMMUNICATIONS (2015)
Toward a crystal-clear view of the viral RNA sensing and response by RIG-I-like receptors
Dahai Luo
RNA BIOLOGY (2014)
Toll-like receptor activation in immunity vs. tolerance in autoimmune diabetes
Elke Guelden et al.
FRONTIERS IN IMMUNOLOGY (2014)
Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
Kai Naumann et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Length of dsRNA (poly I:C) drives distinct innate immune responses, depending on the cell type
M. Firoz Mian et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice
Marc Mueller et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Polyinosinic-Polycytidylic Acid Limits Tumor Outgrowth in a Mouse Model of Metastatic Lung Cancer
Giovanni Forte et al.
JOURNAL OF IMMUNOLOGY (2012)
RLR-mediated production of interferon-β by a human dendritic cell subset and its role in virus-specific immunity
Attila Szabo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell research
Silvia A. Fuertes Marraco et al.
FRONTIERS IN IMMUNOLOGY (2012)
Trial Watch Experimental Toll-like receptor agonists for cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Cross-priming for antitumor CTL induced by soluble Ag plus polyI:C depends on the TICAM-1 pathway in mouse CD11c+/CD8α+ dendritic cells
Masahiro Azuma et al.
ONCOIMMUNOLOGY (2012)
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations
Samar Hamdy et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Tumor eradication by immunotherapy with biodegradable PLGA microspheres-an alternative to incomplete Freund's adjuvant
Marc Mueller et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Microencapsulation of inorganic nanocrystals into PLGA microsphere vaccines enables their intracellular localization in dendritic cells by electron and fluorescence microscopy
Christopher Schliehe et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Toll-like Receptor 3-Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance
Arnold I. Chin et al.
CANCER RESEARCH (2010)
Targeted Activation of RNA Helicase Retinoic Acid-Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells
Kirsten Kuebler et al.
CANCER RESEARCH (2010)
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
Sarah L. Jongbloed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages
Marc Daigneault et al.
PLOS ONE (2010)
The roles of TLRs, RLRs and NLRs in pathogen recognition
Taro Kawai et al.
INTERNATIONAL IMMUNOLOGY (2009)
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response
Stefan Fischer et al.
JOURNAL OF DRUG TARGETING (2009)
Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
B. Jasani et al.
VACCINE (2009)
A clinical grade poly I:C-analogue (Ampligen (R)) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro
H. Navabi et al.
VACCINE (2009)
Recognition of viral single-stranded RNA by Toll-like receptors
Sandra S. Diebold
ADVANCED DRUG DELIVERY REVIEWS (2008)
Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5
Hiroki Kato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses
Eva Schlosser et al.
VACCINE (2008)
Biodegradable nanoparticles for cytosolic delivery of therapeutics
Jaspreet K. Vasir et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
TLR3 is essential for the induction of protective immunity against Punta Toro virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not poly(I:C):: Differential, recognition of synthetic dsRNA molecules
Brian B. Gowen et al.
JOURNAL OF IMMUNOLOGY (2007)
Essential role of mda-5 in type IIFN responses to polyriboinosinic: polyribocytidylic acid and encephalomyocarditis picornavirus
Leonid Gitlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
H Kato et al.
NATURE (2006)
Toll-dependent selection of microbial antigens for presentation by dendritic cells
JM Blander et al.
NATURE (2006)
A cell line model for the differentiation of human dendritic cells
C Berges et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
A Le Bon et al.
NATURE IMMUNOLOGY (2003)
Toll-like receptor expression in murine DC subsets:: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines
AD Edwards et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
分享论文
